About The Lancet Infectious Diseases medical journal

About the journal

The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.

Reach & impact

The Lancet journals are both a destination for publication and a platform to advance the global impact of research. The Lancet team cares that your work is highly visible to a global network of researchers, clinicians, industry professionals, policy makers, media outlets, patients, and the wider public, and we work with you and your affiliated institutions to maximise the impact of your research on the world.

Lancet journals have extensive global reach with more than 84 million annual visits on TheLancet.com and 141 million downloaded articles across TheLancet.com and ScienceDirect.
Lancet Alerts, including our electronic Table of Contents, have over 2.1 million subscriptions.
Lancet journals have more than 1.9 million followers on Twitter, Facebook, LinkedIn, WeChat, and Weibo.
With over 487 thousand annual mentions in news articles, research published in Lancet journals receives regular coverage in influential media such as the Associated Press, BBC, CNN, Financial Times, The Guardian, The New York Times, NPR, and The Washington Post.
Lancet podcasts receive nearly 40,000 listens each month.

The Lancet Infectious Diseases is an internationally trusted source of clinical, public health, and global health knowledge. The Lancet Infectious Diseases has an Impact Factor of 25·071 and is the world-leading infectious diseases journal (2020 Journal Citation Reports®, Clarivate 2021).

We recognise that the Journal Impact Factor is just one measure of a journal's performance and encourage authors to explore additional journal impact metrics, which provide a means to assess our journals. The Lancet Infectious Diseases is also indexed by the following abstracting and indexing services:

CAB Direct
Chemical Abstracts
CrossRef
Cumulative Index to Nursing and Allied Health Literature
Current Contents - Clinical Medicine
Embase
Essential Science Indicators
MEDLINE
PubMed
Science Citation Index Expanded
Scopus

Information for Authors

The Lancet Infectious Diseases considers any original research contribution that advocates change in or illuminates infectious disease clinical practice and informative reviews on any topic connected with infectious diseases. Because the journal has an international readership from a wide range of specialties, it is vital that articles should be written clearly and should not assume a level of knowledge above that of, say, a reasonably well-read, recently qualified, doctor in training. One way to find out if your article is understandable to those reading outside their immediate field of interest is to show the manuscript to colleagues in other specialties. If they find it difficult to follow, so will a good proportion of the readership. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. Further details on the different sections of The Lancet Infectious Diseases, and how to submit to the journal, are provided below. If you require further clarification, the journal's editorial staff will be pleased to help (email [email protected]).

The journal publishes a range of article types that encompass all aspects of infectious diseases and medicine:, Newsdesk, Media Watch, Comment, Correspondence, Original Research, Review, Historical Review, Personal View, Grand Round, and Clinical Picture.

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

Fast-track publication

We understand the pressure authors face to have their voices heard first, and we are committed to publishing important papers fast. Fast-track publication is available on papers of immediate public health or clinical importance, or where timed publication has been agreed.

When requested by authors at submission, original research articles are assessed by the editorial team for their suitability for our fast-track service, and eligible papers are then published within 10 weeks of submission. Papers are subjected to The Lancet's usual rigorous standards of external and statistical peer review, and edited by experienced copy editors to the highest standards .

Manuscript submission

To submit your manuscript to The Lancet Infectious Diseases please visit : http://www.editorialmanager.com/thelancetid

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About our content

The aim of The Lancet Infectious Diseases is to publish interesting and informative research articles and reviews on any topic connected with infectious diseases and human health. Our preference is to publish articles likely to influence clinical practice or thinking. Topics include, but are not limited to:

Anti-infective therapy and immunisation
Bacterial, viral, fungal, and parasitic infections
Emerging infectious diseases
HIV/AIDS, malaria, and tuberculosis and mycobacterial infections
Infection control
Infectious diseases epidemiology
Neglected tropical diseases and travel medicine

Marco De Ambrogi is a Deputy Editor. He studied veterinary medicine at the University of Parma, in Italy, then completed a PhD in endocrinology at the University of Bologna. After several postdoctoral positions at the Royal Veterinary College in London, UK, Marco moved to publishing working first as Editorial Assistant at BioMed Central, then as Associate Editor at Future Medicine and after a span as Medical Writer at Imperial College, he joined Elsevier as Senior Editor for The Lancet Infectious Diseases in 2014. His main interests are parasitology, zoonoses, tropical medicine, and global health and what he enjoys most of his work is the daily contact with people from all parts of the world.

Liam Messin is a Senior Editor. He received a PhD in Interdisciplinary Biomedical Research from Warwick Medical School in 2017. After his PhD he then proceeded to work on the Naked Scientists Radio show. Prior to joining The Lancet Infectious Diseases in 2021 he was a Senior Editor at EBioMedicine and, before that, the Senior Submissions Editor for Medicine and Life Sciences at Springer Nature. His main interests are tuberculosis, malaria and HIV, and the impact of infectious diseases in resource-limited settings.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

April 2022

Volume 22, Issue 4

About The Lancet Infectious Diseases